NCT07757347

Brief Summary

The aim of the present study is to investigate the effect of fructose consumption on health parameters and the intestinal barrier in healthy individuals

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Apr 2026Dec 2027

Study Start

First participant enrolled

April 1, 2026

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

August 11, 2026

Status Verified

April 1, 2026

Enrollment Period

1.2 years

First QC Date

April 30, 2026

Last Update Submit

August 5, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in markers of intestinal permeability

    Changes in concentrations of bacterial endotoxin in blood plasma

    At the end of the treatment (1 month)

  • Cytokine release from blood immune cells stimulated with bacterial toxins

    Changes in cytokine concentration in supernatant of immune cells before and after the treatments

    At the end of the treatment (1 month)

Study Arms (2)

Fructose

EXPERIMENTAL

Following a standardization of their nutritional intake for three days, participants will receive a drink supplemented with free fructose.

Other: Fructose

Glucose

EXPERIMENTAL

Following a standardization of their nutritional intake for three days, participants will receive a drink supplemented with free glucose.

Other: Glucose

Interventions

Following a standardization of their nutritional intake for three days, participants will either receive a drink supplemented with low doses of free fructose (5%).

Also known as: Diet
Fructose
GlucoseOTHER

Following a standardization of their nutritional intake for three days, participants will either receive a drink supplemented with low doses of free glucose (5 %).

Also known as: Diet
Glucose

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all gender, healthy collective ≥ 18 years old

You may not qualify if:

  • Chronic inflammatory diseases of the gastrointestinal tract
  • Metabolic diseases or taking medication to treat metabolic diseases
  • Fructose malabsorption
  • Hereditary fructose intolerance
  • Food intolerances and/or allergies, as well as food allergies that require special dietary interventions
  • Special diets, such as vegetarian/vegan diets
  • Unstable body weight within the last 6 months (fluctuations of \> 5%)
  • BMI \< 19 kg/m2 \& \> 29,9 kg/m2
  • Bariatric surgery
  • Smoking
  • Liver diseases
  • Renal insufficiency
  • Rheumatoid arthritis
  • COPD with ≥ 2 exacerbations per year
  • Chronic pancreatitis or recurrent acute pancreatitis
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vienna

Vienna, 1090, Austria

RECRUITING

MeSH Terms

Interventions

FructoseDietGlucose

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydratesKetosesNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

April 30, 2026

First Posted

August 11, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

August 11, 2026

Record last verified: 2026-04

Locations